MONTELEONE, Palmiero
 Distribuzione geografica
Continente #
NA - Nord America 37.780
AS - Asia 17.330
EU - Europa 11.240
SA - Sud America 1.909
Continente sconosciuto - Info sul continente non disponibili 1.222
AF - Africa 269
OC - Oceania 44
Totale 69.794
Nazione #
US - Stati Uniti d'America 37.139
HK - Hong Kong 5.774
SG - Singapore 4.825
IT - Italia 4.531
CN - Cina 2.750
UA - Ucraina 2.101
VN - Vietnam 1.471
BR - Brasile 1.411
DE - Germania 996
TR - Turchia 787
RU - Federazione Russa 683
IE - Irlanda 630
FR - Francia 621
KR - Corea 500
FI - Finlandia 496
SE - Svezia 479
IN - India 338
CA - Canada 331
GB - Regno Unito 221
BD - Bangladesh 217
AR - Argentina 202
IQ - Iraq 117
JP - Giappone 112
MX - Messico 110
EC - Ecuador 77
AT - Austria 67
PL - Polonia 64
ZA - Sudafrica 64
NL - Olanda 61
PK - Pakistan 61
ID - Indonesia 60
CO - Colombia 53
VE - Venezuela 53
ES - Italia 52
AU - Australia 35
CR - Costa Rica 35
EU - Europa 35
JM - Giamaica 35
MA - Marocco 35
MY - Malesia 35
UZ - Uzbekistan 32
KE - Kenya 31
PH - Filippine 31
CL - Cile 30
JO - Giordania 30
SA - Arabia Saudita 28
EG - Egitto 27
BE - Belgio 26
PE - Perù 25
PY - Paraguay 25
TN - Tunisia 24
CZ - Repubblica Ceca 21
IL - Israele 20
NO - Norvegia 19
CH - Svizzera 18
NP - Nepal 18
GT - Guatemala 17
HN - Honduras 17
RO - Romania 17
AE - Emirati Arabi Uniti 16
BG - Bulgaria 16
DZ - Algeria 16
TT - Trinidad e Tobago 16
LT - Lituania 15
UY - Uruguay 14
BO - Bolivia 13
ET - Etiopia 13
NI - Nicaragua 13
HU - Ungheria 11
PA - Panama 11
PT - Portogallo 11
RS - Serbia 11
SN - Senegal 11
SV - El Salvador 11
AL - Albania 10
AZ - Azerbaigian 10
DO - Repubblica Dominicana 10
GR - Grecia 9
HR - Croazia 9
LB - Libano 9
NG - Nigeria 9
NZ - Nuova Zelanda 9
PR - Porto Rico 9
PS - Palestinian Territory 9
IR - Iran 8
KZ - Kazakistan 8
KG - Kirghizistan 7
OM - Oman 7
BN - Brunei Darussalam 6
EE - Estonia 6
GH - Ghana 6
MD - Moldavia 6
SY - Repubblica araba siriana 6
TW - Taiwan 6
BA - Bosnia-Erzegovina 5
BB - Barbados 5
CW - ???statistics.table.value.countryCode.CW??? 5
MN - Mongolia 5
AO - Angola 4
GE - Georgia 4
Totale 68.505
Città #
Ann Arbor 6.775
Hong Kong 5.751
Woodbridge 2.667
San Jose 2.650
Ashburn 2.645
Jacksonville 2.573
Singapore 2.504
Wilmington 2.311
Chandler 2.163
Princeton 1.910
Milan 1.794
Houston 1.737
Dallas 1.187
Council Bluffs 1.160
Izmir 728
Dublin 620
Dong Ket 610
The Dalles 511
Nanjing 510
Rome 485
Andover 481
Lauterbourg 469
Beijing 443
Boardman 366
Memphis 360
Pellezzano 338
São Paulo 319
Ho Chi Minh City 295
Moscow 244
Düsseldorf 241
Naples 236
Santa Clara 234
Hanoi 207
Los Angeles 193
Hebei 178
Fairfield 172
Shenyang 167
Pune 165
Norwalk 164
New York 162
Mestre 160
Nanchang 157
Toronto 146
Changsha 130
Jiaxing 118
Frankfurt am Main 114
Figino 105
Turin 100
Seattle 98
Tokyo 98
Atlanta 88
Washington 88
Chicago 82
Salerno 81
Tianjin 76
San Francisco 72
Orem 69
Redwood City 67
Brooklyn 64
Phoenix 64
Munich 63
Nuremberg 59
Des Moines 55
Da Nang 54
San Nicola la Strada 50
Warsaw 50
Baghdad 46
Montreal 46
Rio de Janeiro 46
Boston 44
San Diego 44
Columbus 40
Amsterdam 38
Florence 36
Edinburgh 34
Helsinki 33
London 33
Philadelphia 33
Belo Horizonte 32
Cambridge 32
Denver 32
Chennai 30
Amman 28
Bologna 28
Dearborn 28
Dhaka 28
Miami 28
Tashkent 28
Nettuno 27
San José 27
Haiphong 26
Mexico City 26
Hải Dương 25
Buffalo 24
Jinan 24
Johannesburg 24
Nairobi 24
Catania 23
Guayaquil 23
Mumbai 23
Totale 50.096
Nome #
World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of eating disorders. 1.280
Early traumatic experiences and eating disorders: A focus on the endogenous stress response system 665
(+)-N-allylnormetazocine enhances N-acetyltransferase activity and melatonin synthesis: preliminary evidence for a functional role of sigma receptors in the rat pineal gland 546
Assenza di modulazione GABAergica sulla secrezione basale di prolattina e di GH nella schizofrenia cronica 480
Circadian rhythms and treatment implications in depression 473
Enhanced response of ghrelin to sham feeding in patients with anorexia nervosa 463
No association of the Arg51Gln and Leu72Met polymorphisms of the ghrelin gene with anorexia nervosa or bulimia nervosa 453
Pharmacological activation of the GABAergic system does not affect GH and PRL release in acromegaly 381
Accuracy of self-assessment of real-life functioning in schizophrenia 374
Lowered serum dipeptidyl peptidase IV activity in patients with anorexia and bulimia nervosa 360
Ghrelin response to hedonic eating in underweight and short-term weight restored patients with anorexia nervosa 357
Significant Locus and Metabolic Genetic Correlations Revealed in Genome-Wide Association Study of Anorexia Nervosa 337
Effects of trazodone on plasma cortisol in normal subjects. A study with drug plasma levels 320
Health-related quality of life in euthymic bipolar disorder patients: Differences between bipolar I and II subtypes 269
Appropriatezza clinica, strutturale e operativa nella prevenzione, diagnosi e terapia dei disturbi dell’alimentazione 251
Circulating levels of neuroactive steroids in patients with binge eating disorder: a comparison with nonobese healthy controls and non-binge eating obese subjects 247
Serotonin transporter polymorphism and potential response to SSRIs in bulimia nervosa. 243
Mismatch Negativity and P3a Impairment through Different Phases of Schizophrenia and Their Association with Real-Life Functioning 227
Physical exercise at night blunts the nocturnal increase of plasma melatonin levels in healthy humans 224
Childhood trauma and cortisol awakening response in symptomatic patients with anorexia nervosa and bulimia nervosa 222
Analysis of shared heritability in common disorders of the brain 219
Melanocortin-4 receptor molecular scanning and pro-opiomelanocortin R236G variant screening in binge eating disorder 215
3111T/C polymorphism of the clock gene confers a predisposition to a lifetime lower body weight in anorexia and bulimia nervosa 214
A 4-year epidemiological study of typical and atypical eating disorders: preliminary evidence for subgroups of atypical eating disorders with different natural outcomes 200
The human pineal gland responds to stress-induced sympathetic activation in the second half of the dark phase: preliminary evidence 195
Altered processing of rewarding and aversive basic taste stimuli in symptomatic women with anorexia nervosa and bulimia nervosa: An fMRI study 195
Serotonergic modulation of rat pineal gland activity: in vivo evidence for a 5-Hydroxytryptamine(2C) receptor involvement 190
Alterazioni neuroendocrine nella depressione stagionale 190
Altered immunoreactive levels of G proteins in peripheral mononuclear cells of patients with anorexia nervosa and bulimia nervosa 185
An epidemiological study on eating disorders in two high schools in Naples 183
World Federation of Societies of Biological Psychiatry (WFSBP) guidelines update 2023 on the pharmacological treatment of eating disorders 179
Serotonin Trasporter Polymorphisms And Ssri Response In Bulimia Nervosa 179
Growth hormone response to GABA?B receptor activation in depressed patients before and after antidepressant therapy 174
Lateralization patterns of verbal stimuli processing assessed by reaction time and event-related potentials in schizophrenic patients 174
Are antipsychotics useful in the treatment of anorexia nervosa? 173
Leptin secretion is related to chronicity and severity of the illness in bulimia nervosa 173
Aggressive behavioral characteristics and endogenous hormones in women with Bulimia nervosa 172
Regolazione del comportamento alimentare e correlati biochimici dell’anoressia e bulimia nervosa 171
Association of CNR1 and FAAH endocannabinoid gene polymorphisms with anorexia nervosa and bulimia nervosa: evidence for synergistic effects 170
The 196G/A (val66met) polymorphism of the BDNF gene is significantly associated with binge eating behavior in women with bulimia nervosa or binge eating disorder 166
Deranged endocannabinoid responses to hedonic eating in underweight and recently weight-restored patients with anorexia nervosa 166
Evidence for opiate and estrogen interaction on neurohormonal secretion 164
Differences between morning and afternoon hormonal responses to D-fenfluramine in healthy humans 164
Chronic antidepressant drug treatment does not affect GH response to baclofen in depressed subjects 163
Test alla d-fenfluramina e risposta al trattamento farmacologico nei pazienti con sindrome ossessivo-compulsiva 162
Assessment of Response to Lithium Maintenance Treatment in Bipolar Disorder: A Consortium on Lithium Genetics (ConLiGen) Report. 161
Effects of acute and chronic haloperidol administration on the nocturnal activity of the rat pineal gland in vivo 160
Interhemispheric functional connectivity in anorexia and bulimia nervosa 160
The family of a patient with an eating disorder 159
Risposta della prolattina alla d-fenfluramina in pazienti con sindrome ossessivo-compulsiva prima e dopo terapia con fluvoxamina 159
Correlations between negative symptoms and peripheral G protein levels in mononuclear leukocytes of deficit and nondeficit schizophrenics. Preliminary results 158
[Evaluation of therapeutic efficacy and pharmacokinetics of controlled release of trazodone in patients with major depressive disorder] 157
Naloxone-induced decrease of plasma prolactin in healthy women 156
A comparative study of melatonin production in the retina, pineal gland and harderian gland of Bufo viridis and Rana esculenta 156
Impulsiveness in patients with bulimia nervosa: electrophysiological evidence of reduced inhibitory control. 156
Acute trazodone administration decreases plasma cortisol levels in healthy subjects. 155
G-PROTEIN IMMUNOREACTIVITY LEVELS IN LYMPHOCYTES OF DEFICIT AND NONDEFICIT SCHIZOPHRENIC PATIENTS 155
Evidence that cholinergic receptors of muscarinic type may modulate vasopressin release induced by metoclopramide 155
Valutazione dinamica dell’asse ipotalamo-ipofisi- surrene e del Sistema Nervoso Simpatico in risposta ad uno stress psicosociale nei Disturbi del Comportamento Alimentare 154
Brain-derived neurotrophic factor (BDNF) and eating behaviour in bulimia nervosa and binge eating disorder 154
The treatment of unipolar depression by lithium salts 153
The circadian basis of mood disorders: Recent developments and treatment implications 153
Self-injurious behavior and attempted suicide in purging bulimia nervosa: Associations with psychiatric comorbidity 153
Baclofen-induced growth hormone secretion is blunted in chronic schizophrenics: neuroendocrine evidence for a GABA disturbance in schizophrenia 153
Differences in Cortisol Awakening Response between Binge-Purging and Restrictive Patients with Anorexia Nervosa 153
Effect of pharmacological activation of gamma?aminobutyric acid system on basal pituitary secretion in humans 151
Cortisol response to d-fenfluramine in patients with obsessive-compulsive disorder and in healthy subjects: evidence for a gender-related effect 151
Melatonin and cortisol secretion in patients with primary obsessive-compulsive disorder 151
NEUROENDOCRINOLOGY OF EATING DISORDERS: RECENT ADVANCES AND FUTURE PERSPECTIVES 150
The acute salivary ghrelin response to a psychosocial stress is enhanced in symptomatic patients with bulimia nervosa: a pilot study. 150
Responses of peripheral endocannabinoids and endocannabinoid-related compounds to hedonic eating in obesity 150
Interplay among psychopathologic variables, personal resources, context-related factors, and real-life functioning in individuals with schizophrenia a network analysis 150
Development and validation of the family coping questionnaire for eating disorders 149
Aripiprazole augmentation strategy in clomipramine-resistant depressive patients: an open preliminary study. 149
Plasma concentrations of amino acids in chronic schizophrenics treated with clozapine 149
2-[125]Iodomelatonin binding sites in the brain retina and Harderian gland of the green frog Rana esculenta 149
Alexithymia and cortisol awakening response in people with eating disorders 149
Neuroendocrine effect of short term activation of GABAergic system in schizophrenics with and without tardive dyskinesia 148
Dysfunctions of leptin, ghrelin, BDNF and endocannabinoids in eating disorders: beyond the homeostatic control of food intake. 148
Brain-derived neurtrophic factor in mood disorders: reply to Kapczinski et al.’s comment 147
Hormonal changes in obsessive-compulsive disorder: preliminary data on melatonin, prolactin and cortisol circadian rhythms 146
Combined alpha-adrenergic stimulation results in biphasic response of growth hormone release in man 146
Psychobiology of eating disorders 146
Anoressia e Bulimia Nervosa - NOOS 146
Ruolo della melatonina nella regolazione dei ritmi circadiani e stagionali 146
A genome-wide association study of anorexia nervosa suggests a risk locus implicated in dysregulated leptin signaling 146
Asymmetry of salivary cortisol and α-amylase responses to psychosocial stress in anorexia nervosa but not in bulimia nervosa 145
Association of a functional serotonin transporter gene polymorphism with binge eating disorder 145
Plasma melatonin levels following acute diazepam administration in healthy men 144
TIME COURSES OF CLOZAPINE RESPONSE AND CLOZAPINE PLASMA LEVELS: A ONE-YEAR PROSPECTIVE STUDY IN DRUG RESISTANT SCHIZOPHRENIC PATIENTS 144
Underweight subjects with anorexia nervosa have an enhanced salivary cortisol response not seen in weight restored subjects with anorexia nervosa 144
Central and peripheral peptide regulation of hunger. Satiety and food intake in eating disorders 143
The Brief Negative Symptom Scale (BNSS): Independent validation in a large sample of Italian patients with schizophrenia 143
Regolatori centrali e periferici di fame e sazietà nei disturbi del comportamento alimentare 142
Effect of physical stress on nighttime plasma melatonin levels in humans 142
Plamsa leptin response to acute fasting and refeeding in untreated women with bulimia nervosa 142
Association between A218C polymorphism of the tryptophan-hydroxylase-1 gene, harm avoidance and binge eating behavior in bulimia nervosa 142
Circadian Rhythm disturbances in depression: implications for treatment and quality of remission 141
Effects of short‑term administration of phosphatidylserine on the neuroendocrine response to physical stress in humans. 141
Circulating ghrelin is decreased in non-obese and obese women with binge eating disorder as well as in obese non-binge eating women, but not in patients with bulimia nervosa 141
Totale 20.944
Categoria #
all - tutte 220.928
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 220.928


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20223.301 0 0 0 29 36 22 50 129 517 439 445 1.634
2022/20235.458 616 249 224 479 786 1.162 23 607 737 39 405 131
2023/20242.575 226 332 174 78 153 420 147 241 42 158 201 403
2024/20254.338 328 78 131 148 164 561 610 704 672 194 355 393
2025/202622.629 1.384 2.949 3.484 666 2.189 1.243 3.609 717 1.043 1.895 663 2.787
2026/20276.727 1.341 686 2.307 2.393 0 0 0 0 0 0 0 0
Totale 69.794